JP2020531514A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531514A5
JP2020531514A5 JP2020511214A JP2020511214A JP2020531514A5 JP 2020531514 A5 JP2020531514 A5 JP 2020531514A5 JP 2020511214 A JP2020511214 A JP 2020511214A JP 2020511214 A JP2020511214 A JP 2020511214A JP 2020531514 A5 JP2020531514 A5 JP 2020531514A5
Authority
JP
Japan
Prior art keywords
receptor
rage
modulator according
modulator
cytoplasmic tail
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020511214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531514A (ja
JP7865475B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050883 external-priority patent/WO2019036753A1/en
Publication of JP2020531514A publication Critical patent/JP2020531514A/ja
Publication of JP2020531514A5 publication Critical patent/JP2020531514A5/ja
Priority to JP2023121818A priority Critical patent/JP7855180B2/ja
Priority to JP2025227130A priority patent/JP2026062654A/ja
Application granted granted Critical
Publication of JP7865475B2 publication Critical patent/JP7865475B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020511214A 2017-08-22 2018-08-21 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 Active JP7865475B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023121818A JP7855180B2 (ja) 2017-08-22 2023-07-26 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節
JP2025227130A JP2026062654A (ja) 2017-08-22 2025-12-03 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2017903381A AU2017903381A0 (en) 2017-08-22 Screening Assays, Modulators and Modulation of Activation of Receptor For Advanced Glycation End-Products (RAGE)
AU2017903381 2017-08-22
AU2018902298A AU2018902298A0 (en) 2018-06-26 Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE)
AU2018902298 2018-06-26
PCT/AU2018/050883 WO2019036753A1 (en) 2017-08-22 2018-08-21 SCREENING TESTS, MODULATORS AND MODULATION OF RECEIVER ACTIVATION FOR ADVANCED GLYCATION TERMINAL PRODUCTS (RAGE)

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2023121818A Division JP7855180B2 (ja) 2017-08-22 2023-07-26 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節
JP2025227130A Division JP2026062654A (ja) 2017-08-22 2025-12-03 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Publications (3)

Publication Number Publication Date
JP2020531514A JP2020531514A (ja) 2020-11-05
JP2020531514A5 true JP2020531514A5 (cg-RX-API-DMAC7.html) 2021-09-30
JP7865475B2 JP7865475B2 (ja) 2026-05-26

Family

ID=65438276

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020511214A Active JP7865475B2 (ja) 2017-08-22 2018-08-21 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節
JP2023121818A Active JP7855180B2 (ja) 2017-08-22 2023-07-26 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節
JP2025227130A Pending JP2026062654A (ja) 2017-08-22 2025-12-03 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023121818A Active JP7855180B2 (ja) 2017-08-22 2023-07-26 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節
JP2025227130A Pending JP2026062654A (ja) 2017-08-22 2025-12-03 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Country Status (7)

Country Link
US (2) US12060408B2 (cg-RX-API-DMAC7.html)
EP (1) EP3672982B1 (cg-RX-API-DMAC7.html)
JP (3) JP7865475B2 (cg-RX-API-DMAC7.html)
CN (2) CN120607606A (cg-RX-API-DMAC7.html)
AU (1) AU2018322482B2 (cg-RX-API-DMAC7.html)
CA (1) CA3109871A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019036753A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3109871A1 (en) * 2017-08-22 2019-02-28 Monash University Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage)
KR102203850B1 (ko) * 2019-04-09 2021-01-18 사회복지법인 삼성생명공익재단 신경교종의 진단 또는 예후 예측용 조성물 및 이에 관한 정보를 제공하는 방법
EP4168548A1 (en) 2020-06-22 2023-04-26 Regeneron Pharmaceuticals, Inc. Treatment of obesity with g-protein coupled receptor 75 (gpr75) inhibitors
WO2022150709A1 (en) * 2021-01-11 2022-07-14 President And Fellows Of Harvard College Compositions and methods for treating viral infection
CN113293212A (zh) * 2021-06-17 2021-08-24 深圳华因康基因科技有限公司 一种检测神经母细胞瘤复发转移基因fzd2扩增的引物探针及其应用
CN113789379B (zh) * 2021-08-30 2022-08-23 远见生物科技(上海)有限公司 一种检测前列腺癌的诊断试剂盒及其检测方法与应用
JP2023084477A (ja) * 2021-12-07 2023-06-19 花王株式会社 硫黄化合物を原因とするにおいの抑制剤の評価及び/又は選択方法
WO2023140700A1 (ko) 2022-01-24 2023-07-27 서울대학교산학협력단 장 미각 수용체 tas1r3 발현 및 활성화 억제를 통한 서구식 식이 유발 염증성 장 질환의 예방 또는 치료
WO2023164290A2 (en) * 2022-02-28 2023-08-31 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and compositions for treating cancers and other proliferative disorders
KR20230147988A (ko) * 2022-04-15 2023-10-24 아주대학교산학협력단 Rage 길항제 및 age 소거제를 포함하는 당뇨성 뇌졸중 예방 또는 치료용 약학적 조성물
WO2024044659A1 (en) * 2022-08-24 2024-02-29 Tectonic Therapeutic, Inc. Constitutively active g protein-coupled receptor compositions and methods of use thereof
CN115798616B (zh) * 2022-10-26 2026-06-19 大连大学 基于dna链置换的新型生物分子控制器的实现方法
CN118777620A (zh) * 2023-04-07 2024-10-15 浙江友宁生物医药科技有限公司 Gpr139受体激活检测方法、生理功能评价方法及应用
CN116410335B (zh) * 2023-04-24 2024-08-13 徐州医科大学 一种多肽tat-mrgprx1c及其应用
CN118755834B (zh) * 2024-07-15 2025-11-18 河北医科大学第四医院(河北省肿瘤医院) 胃癌复发预测模型
CN119901926A (zh) * 2025-03-31 2025-04-29 浙江省立同德医院(浙江省精神卫生研究院) 一种基于rage过表达和spr技术的rage靶向药物筛选方法
CN121695261B (zh) * 2026-02-11 2026-04-17 湖南启元生物科技有限公司 一种蛋白组合物及其制备方法
CN121774990A (zh) * 2026-03-05 2026-04-03 浙江省中医院、浙江中医药大学附属第一医院(浙江省东方医院) 七叶皂苷钠在制备防治糖尿病视网膜病变药物中的应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US5004687A (en) 1985-05-21 1991-04-02 University Of Georgia Research Foundation, Inc. Insect virus vector with broadened host range
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5273876A (en) 1987-06-26 1993-12-28 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene
CA2045129A1 (en) 1989-02-01 1990-08-02 Alfred I. Geller Herpes simplex virus type i expression vector
GB8923123D0 (en) 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
EP0549723A1 (en) 1990-09-21 1993-07-07 Chiron Corporation Packaging cells
ATE188740T1 (de) 1991-02-19 2000-01-15 Univ California Viruspartikel mit veraendertem wirtspektrum
GB9105383D0 (en) 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
US6013638A (en) 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
EP0552108B1 (en) 1992-01-17 1999-11-10 Lakowicz, Joseph R. Energy transfer phase-modulation fluoro-immunoassay
AU3972893A (en) 1992-04-03 1993-11-08 Baylor College Of Medicine Gene therapy using the intestine
US6130074A (en) 1992-06-01 2000-10-10 American Cyanamid Company Five Giralda Farms Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
SE9201984D0 (sv) 1992-06-29 1992-06-29 Pharmacia Biosensor Ab Improvement in optical assays
JP3147514B2 (ja) 1992-07-08 2001-03-19 住友電装株式会社 電線送給装置
AU6014094A (en) 1992-12-02 1994-06-22 Baylor College Of Medicine Episomal vectors for gene therapy
AU680508B2 (en) 1993-04-06 1997-07-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Gibbon ape leukemia virus-based retroviral vectors
US6133028A (en) 1993-05-28 2000-10-17 Transgene S.A. Defective adenoviruses and corresponding complementation lines
US6120764A (en) 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
US6140087A (en) 1993-06-24 2000-10-31 Advec, Inc. Adenovirus vectors for gene therapy
AU7353494A (en) 1993-11-12 1995-05-29 Case Western Reserve University Episomal expression vector for human gene therapy
US5731172A (en) 1994-03-09 1998-03-24 Sumitomo Pharmaceuticals Company, Ltd. Recombinant adenovirus and process for producing the same
US5833993A (en) 1994-04-29 1998-11-10 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US5604090A (en) 1994-06-06 1997-02-18 Fred Hutchinson Cancer Research Center Method for increasing transduction of cells by adeno-associated virus vectors
US5662897A (en) 1994-07-27 1997-09-02 U. Of Ga Research Foundation Insect viruses, sequences, insecticidal compositions and methods of use
US5693508A (en) 1994-11-08 1997-12-02 Chang; Lung-Ji Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
JP3770333B2 (ja) 1995-03-15 2006-04-26 大日本住友製薬株式会社 組換えdnaウイルスおよびその製造方法
GB9506782D0 (en) 1995-04-01 1995-05-24 British Biotech Pharm Retroviral vectors
CA2226575C (en) 1995-07-27 2011-10-18 Genentech, Inc. Stabile isotonic lyophilized protein formulation
JPH11511326A (ja) 1995-08-30 1999-10-05 ジエンザイム コーポレイション アデノウィルスおよびaavの精製
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US6020192A (en) 1996-01-18 2000-02-01 University Of Florida Humanized green fluorescent protein genes and methods
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
CA2247091A1 (en) 1996-03-05 1997-09-12 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral dna vaccines
US5952221A (en) 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
US5891646A (en) 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US6143565A (en) 1997-08-22 2000-11-07 The United States Of America As Represented By The Secretary Of Agriculture Stable insect virus-cell expression system
US6893827B1 (en) 2000-02-07 2005-05-17 Applera Corporation Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
EP1345968A2 (en) 2000-12-28 2003-09-24 Altus Biologics Inc. Crystals of whole antibodies and fragments thereof and methods for making and using them
JPWO2003008446A1 (ja) 2001-07-19 2004-11-11 三菱ウェルファーマ株式会社 後期糖化産物受容体のシグナル伝達に関連するポリペプチド
CN1894581B (zh) 2003-07-09 2012-02-01 生命技术公司 检测蛋白-蛋白相互作用的方法
US7488583B2 (en) 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
ES2473587T3 (es) 2004-08-03 2014-07-07 Transtech Pharma, Inc. Proteínas de fusión de RAGE y métodos de uso
EP1869464A4 (en) 2005-03-17 2009-12-02 Univ Columbia RAGE-DIAPHANOUS INTERACTION AND CORRESPONDING COMPOSITIONS AND METHODS
JP5295785B2 (ja) 2006-02-20 2013-09-18 エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション 細胞膜透過性ペプチド
MX2008011933A (es) 2006-03-21 2008-12-18 Wyeth Corp Metodos y composiciones para antagonismo de rage.
WO2008055314A1 (en) 2006-11-10 2008-05-15 Dimerix Bioscience Pty Ltd Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
WO2008154638A2 (en) 2007-06-12 2008-12-18 Board Of Regents, The University Of Texas System Antagonists of the receptor for advanced glycation end-products (rage)
US8101373B2 (en) 2007-10-12 2012-01-24 Discoverx Corporation β-galactosidase donor fragments
WO2012109569A1 (en) 2011-02-11 2012-08-16 The Trustees Of Columbia University In The City Of New York The receptor for advanced glycation endproducts (rage) is a receptor for lysophosphatidic acid (lpa)
WO2012159164A1 (en) 2011-05-23 2012-11-29 Phylogica Limited Method of determining, identifying or isolating cell-penetrating peptides
EP2756005B1 (en) 2011-09-14 2016-03-02 Abeterno Technologies Limited Intracellular cell selection
CA3109871A1 (en) * 2017-08-22 2019-02-28 Monash University Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage)

Similar Documents

Publication Publication Date Title
Toro et al. MaxiK channel and cell signalling
JP7212009B2 (ja) Cxcr4結合分子
US8440627B2 (en) G protein coupled receptor agonists and antagonists and methods of use
EP2970415B1 (en) Apelin fusion proteins and uses thereof
AU2006212813B2 (en) Compositions and methods related to soluble G-protein coupled receptors (sGPCRs)
AU2018322482B2 (en) Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (RAGE)
Perlman et al. Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor.
CN110225924A (zh) 松弛素融合多肽及其用途
Kolakowski et al. Probing the “Message: Address” Sites for Chemoattractant Binding to the C5a Receptor: MUTAGENESIS OF HYDROPHILIC AND PROLINE RESIDUES WITHIN THE TRANSMEMBRANE SEGMENTS
CN114591415B (zh) Glp-1/gcg双受体激动剂多肽及其融合蛋白
Lin et al. GPS proteolytic cleavage of adhesion-GPCRs
US20110230401A1 (en) Insulin fusion polypeptides
EP2480568A1 (en) Polypeptides and nucleic acids for treating erbb2-dependent cancers
Schneider et al. Histamine H4 receptor–RGS fusion proteins expressed in Sf9 insect cells: A sensitive and reliable approach for the functional characterization of histamine H4 receptor ligands
US20080206231A1 (en) Compositions and Methods for Treating Disease
Li et al. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain
Lallement et al. Cholecystokinin and gastrin are not equally sensitive to GTPγS at CCKB receptors: importance of the sulphated tyrosine
Tomasovic et al. Role of Cbl-associated protein/ponsin in receptor tyrosine kinase signaling and cell adhesion
KR102778534B1 (ko) G 단백질 알파 서브유닛의 알파-헬리컬 도메인의 실시간 구조 변화 확인 방법 및 시스템
Raingeaud et al. Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs
Rached et al. Stable expression of human melanocortin 3 receptor fused to EGFP in the HEK293 cells
Kakizawa Apelin
Won et al. The GTPase domain of Galphao contributes to the functional interaction of Galphao with the promyelocytic leukemia zinc finger protein
Niimi et al. Expression of the Long Arm Sequence of Mouse Laminin α1, β1, or γ; l Chain in COSl Cells and Assembly of Monkey-Mouse Hybrid Laminin
US20080160552A1 (en) Methods and Compounds for Treating Inflammation